Aurora Cannabis Inc is gaining traction on the TSX, buoyed by impressive revenue growth and strategic expansions.
Aurora Cannabis Inc (ACB.TO) is rising today, with a 3.20% increase in its stock price, closing at CA$5.16. The company is seeing a positive market response following its recent fiscal results, which show significant year-over-year growth in revenue and adjusted EBITDA.
Advertisement
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeAdvertisement
Market cap
$316.52M
52W high
$9.33
52W low
$3.59
1W change
+24.07%
Beta
1.34
Analyst Price Targets
Based on analyst covering ACB
Wall Street analysts forecast ACB stock price to rise 11.2% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.56
+11.2% Upside
Current Price
C$5.00
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
74.0%
Annualized
90-Day Vol
61.2%
Annualized
Trend (90d)
+5.9%
Annualized drift
90d Mean
C$5.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$5.04 | C$3.90 – C$6.50 |
| 60 trading days | C$5.07 | C$3.53 – C$7.28 |
| 90 trading days | C$5.11 | C$3.28 – C$7.95 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors are responding favorably to Aurora's strong financial performance and strategic initiatives, indicating potential for continued growth in the cannabis sector.
3.20% Increase in Stock Price
Aurora's stock price has risen to CA$5.16, reflecting strong investor confidence after impressive fiscal results.
Bull case
The company reported a remarkable 37% increase in global medical cannabis net revenue, along with positive free cash flow. This suggests that Aurora is on solid financial ground.
Bear case
Despite the positive growth, Aurora still operates at a loss with a negative profit margin, which could raise concerns for investors about long-term sustainability.
Strong Financial Performance
Advertisement
Aurora Cannabis has reported a 37% year-over-year increase in global medical cannabis net revenue, reaching CA$64.8 million. This growth is driven by an impressive 85% rise in international revenue, totaling CA$37.1 million. The company also achieved significant adjusted EBITDA growth of over 200%, totaling CA$10.8 million.
Positive Market Response
Investors have reacted positively to Aurora's strong financial results, as seen in the stock's rise. With a market cap of approximately CA$316.5 million and a solid cash position of CA$186 million with no debt, Aurora is well-positioned for future growth in the competitive cannabis market.
Strategic Initiatives and Future Outlook
Aurora's recent initiatives, including product launches in key international markets and the acquisition of Safari Flower Company, enhance its ability to serve a growing customer base. These strategic moves could further solidify its market position and drive continued revenue growth.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
